The following table summarizes the components of the purchase consideration (in thousands): (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Jun. 30, 2023 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
Business Acquisition [Line Items] | |||
Closing cash consideration | $ 22,174 | ||
Upsher-Smith Laboratories, LLC [Member] | |||
Business Acquisition [Line Items] | |||
Closing cash consideration | $ 22,174 | ||
Inventory adjustment payment liability | 1,348 | ||
Deferred payment liability | 3,000 | ||
Purchase price to be allocated | $ 26,522 |
X | ||||||||||
- Definition Amount of adjustment to business combination consideration upon the determination of the value of acquired inventory. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|